1996
DOI: 10.1111/j.1600-0714.1996.tb00207.x
|View full text |Cite
|
Sign up to set email alerts
|

Cyclosporin‐ and nifedipine‐induced gingival overgrowth in renal transplant patients: correlations with periodontal and pharmacological parameters, and HLA‐antigens

Abstract: The factors associated with cyclosporin A (CsA)- and nifedipine (Nif)-induced gingival overgrowth were investigated in 113 renal transplant recipients receiving CsA alone (Group 1) [n = 61], CsA and Nif (Group 2) [n = 28], or azathioprine (Aza) (Control Group) [n = 24]. Periodontal and pharmacological parameters were assessed for each patient. The patients with a gingival overgrowth index (GOI) score >1 were considered responders (R); those with a score Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
47
0
4

Year Published

1999
1999
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 57 publications
(55 citation statements)
references
References 26 publications
(32 reference statements)
4
47
0
4
Order By: Relevance
“…The prevalence of DIGO has been reported to be between 20% and 85% [20][21][22][23]. In agreement with the literature, our baseline evaluation found that 65% of our study population had DIGO.…”
Section: Discussionsupporting
confidence: 91%
“…The prevalence of DIGO has been reported to be between 20% and 85% [20][21][22][23]. In agreement with the literature, our baseline evaluation found that 65% of our study population had DIGO.…”
Section: Discussionsupporting
confidence: 91%
“…They concluded that local factors and pharmacological p a r a m e t e rs were unrelated to ove r gr owth and indicated a trend for HLA A19-positive patients to show signs of gingival overgrowth, suggesting an underlying genetic susceptibility. 101 Further studies of renal and cardiac transplant patients have suggested that while the incidence of clinically significant gi n gi val ove r gr owth may be s i m i l a r , the seve rity of ove r gr owth appears to be significantly greater in those receiving both Cs and nifedipine. 102 Patients taking both drugs had significantly higher gingival overgrowth scores, probing depths and a greater need for surgery.…”
Section: Combinations Of Medications Associated With Gingival O Vergrmentioning
confidence: 99%
“…The prominent side-effect of CsA therapy in oral tissue is gingival overgrowth (GO; Bennet and Christian 1982;Wysocki et al 1983) with a prevalence ranging from 2% to 70% (Margiotta et al 1996). However, the precise molecular mechanisms underlying this development are still not elucidated.…”
Section: Introductionmentioning
confidence: 98%